PT  - JOURNAL ARTICLE
AU  - Henri Berestycki
AU  - Benoît Desjardins
AU  - Bruno Heintz
AU  - Jean-Marc Oury
TI  - Plateaus, Rebounds and the Effects of Individual Behaviours in Epidemics
AID  - 10.1101/2021.03.26.21254414
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.26.21254414
4099  - http://medrxiv.org/content/early/2021/08/21/2021.03.26.21254414.short
4100  - http://medrxiv.org/content/early/2021/08/21/2021.03.26.21254414.full
AB  - Plateaus and rebounds of various epidemiological indicators are widely reported in Covid-19 pandemics studies but have not been explained so far. Here, we address this problem and explain the appearance of these patterns. We start with an empirical study of an original dataset obtained from highly precise measurements of SARS-Cov-2 concentration in wastewater over nine months in several treatment plants around the Thau lagoon in France. Among various features, we observe that the concentration displays plateaus at different dates in various locations but at the same level. In order to understand these facts, we introduce a new mathematical model that takes into account the heterogeneity and the natural variability of individual behaviours. Our model shows that the distribution of risky behaviours appears as the key ingredient for understanding the observed temporal patterns of epidemics.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funds were received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and codes will be made available upon publication in a journal.